Gambogic acid attenuates liver fibrosis by inhibiting the PI3K/AKT and MAPK signaling pathways via inhibiting HSP90

Zhenlong Yu(Dalian Medical University), Xiaochi Ma(Shandong University), Xiangge Tian(Dalian Medical University), Xiaokui Huo(Dalian Medical University), Cheng‐Peng Sun(Nanchang University), Lu Cai(Dalian Medical University), Lei Feng(Dalian Medical University), Yanan Jv(Dalian Medical University), Chao Wang(McLean Hospital), Baojing Zhang(Dalian Medical University), Jing Ning(Dalian Medical University), Hou-Li Zhang(Dalian Medical University)
Toxicology and Applied Pharmacology
April 3, 2019
Cited by 45


Related Papers